Idexx Laboratories Posts 43.4x Forward P/E, Value Grade D Versus Sonova’s B
Idexx Laboratories carries a forward P/E of 43.44 versus Sonova Holding’s 20.72 and a PEG ratio of 3.84 compared with 3.14 at Sonova. Sonova holds a Value grade of B under traditional metrics like P/E, P/S and P/B, while Idexx earns a Value grade of D.
1. Zacks Rank and Earnings Outlook
Idexx Laboratories holds a Zacks Rank of #3 (Hold), indicating neutral earnings estimate revisions, while Sonova Holding carries a Rank of #2 (Buy) on stronger upward estimate revisions, suggesting a more favorable near-term earnings outlook for Sonova.
2. Valuation Metrics Comparison
Idexx trades at a forward P/E of 43.44 compared with 20.72 for Sonova, and its PEG ratio stands at 3.84 versus Sonova’s 3.14. The P/B ratio for Idexx is 31.37 against Sonova’s 4.94, highlighting a steep premium for Idexx shares.
3. Value Grades and Investment Implications
Under traditional value analysis, Sonova earns a grade of B based on P/E, P/S, earnings yield and cash flow metrics, while Idexx scores D, signaling potential overvaluation and a stronger value case for Sonova shares.